SPX4,076.57-3.54 -0.09%
DIA344.41-1.74 -0.50%
IXIC11,482.45+14.45 0.13%

--Oppenheimer Adjusts Cymabay Therapeutics Price Target to $10 From $12, Maintains Outperform Rating

--Oppenheimer Adjusts Cymabay Therapeutics Price Target to $10 From $12, Maintains Outperform Rating

MT Newswires · 11/16/2022 03:26

Please log in to view news